Gerrit Klaerner sold $1.74M worth of shares in Tricida, Inc. in December 2019

Jan 08, 2020
Insider Transactions
Background Information
Tricida, Inc. is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.